Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 11 |
NetGPI | no | yes: 0, no: 11 |
Term | Name | Level | Count |
---|---|---|---|
GO:0005739 | mitochondrion | 5 | 1 |
GO:0043226 | organelle | 2 | 1 |
GO:0043227 | membrane-bounded organelle | 3 | 1 |
GO:0043229 | intracellular organelle | 3 | 1 |
GO:0043231 | intracellular membrane-bounded organelle | 4 | 1 |
GO:0110165 | cellular anatomical entity | 1 | 1 |
Related structures:
AlphaFold database: A4HQ29
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_C14_Caspase3-7 | 122 | 126 | PF00656 | 0.374 |
CLV_C14_Caspase3-7 | 196 | 200 | PF00656 | 0.360 |
CLV_MEL_PAP_1 | 133 | 139 | PF00089 | 0.334 |
CLV_NRD_NRD_1 | 206 | 208 | PF00675 | 0.487 |
CLV_PCSK_KEX2_1 | 152 | 154 | PF00082 | 0.564 |
CLV_PCSK_KEX2_1 | 206 | 208 | PF00082 | 0.503 |
CLV_PCSK_PC1ET2_1 | 152 | 154 | PF00082 | 0.564 |
CLV_PCSK_SKI1_1 | 157 | 161 | PF00082 | 0.473 |
CLV_PCSK_SKI1_1 | 222 | 226 | PF00082 | 0.474 |
DEG_APCC_DBOX_1 | 77 | 85 | PF00400 | 0.485 |
DOC_PP2B_LxvP_1 | 190 | 193 | PF13499 | 0.377 |
DOC_PP2B_LxvP_1 | 252 | 255 | PF13499 | 0.235 |
DOC_PP4_FxxP_1 | 45 | 48 | PF00568 | 0.368 |
DOC_USP7_MATH_1 | 143 | 147 | PF00917 | 0.367 |
DOC_USP7_MATH_1 | 151 | 155 | PF00917 | 0.357 |
DOC_USP7_MATH_1 | 227 | 231 | PF00917 | 0.525 |
DOC_USP7_MATH_1 | 255 | 259 | PF00917 | 0.482 |
DOC_USP7_MATH_1 | 73 | 77 | PF00917 | 0.485 |
DOC_USP7_UBL2_3 | 107 | 111 | PF12436 | 0.515 |
DOC_WW_Pin1_4 | 214 | 219 | PF00397 | 0.384 |
DOC_WW_Pin1_4 | 44 | 49 | PF00397 | 0.529 |
LIG_14-3-3_CanoR_1 | 69 | 77 | PF00244 | 0.393 |
LIG_APCC_ABBA_1 | 53 | 58 | PF00400 | 0.252 |
LIG_BIR_II_1 | 1 | 5 | PF00653 | 0.436 |
LIG_BRCT_BRCA1_1 | 70 | 74 | PF00533 | 0.511 |
LIG_FHA_1 | 103 | 109 | PF00498 | 0.295 |
LIG_FHA_1 | 119 | 125 | PF00498 | 0.378 |
LIG_FHA_1 | 247 | 253 | PF00498 | 0.358 |
LIG_FHA_2 | 194 | 200 | PF00498 | 0.524 |
LIG_LIR_Gen_1 | 158 | 167 | PF02991 | 0.377 |
LIG_LIR_Gen_1 | 6 | 14 | PF02991 | 0.345 |
LIG_LIR_Nem_3 | 158 | 162 | PF02991 | 0.404 |
LIG_LIR_Nem_3 | 6 | 10 | PF02991 | 0.346 |
LIG_LIR_Nem_3 | 76 | 80 | PF02991 | 0.365 |
LIG_Pex14_2 | 267 | 271 | PF04695 | 0.278 |
LIG_PTB_Apo_2 | 136 | 143 | PF02174 | 0.270 |
LIG_SH2_CRK | 166 | 170 | PF00017 | 0.459 |
LIG_SH2_NCK_1 | 166 | 170 | PF00017 | 0.426 |
LIG_SH2_NCK_1 | 57 | 61 | PF00017 | 0.408 |
LIG_SH2_SRC | 197 | 200 | PF00017 | 0.467 |
LIG_SH2_STAP1 | 234 | 238 | PF00017 | 0.542 |
LIG_SH2_STAP1 | 7 | 11 | PF00017 | 0.437 |
LIG_SH2_STAT3 | 180 | 183 | PF00017 | 0.265 |
LIG_SH2_STAT5 | 17 | 20 | PF00017 | 0.433 |
LIG_SH2_STAT5 | 197 | 200 | PF00017 | 0.372 |
LIG_SH2_STAT5 | 234 | 237 | PF00017 | 0.461 |
LIG_SH2_STAT5 | 80 | 83 | PF00017 | 0.477 |
LIG_WW_1 | 4 | 7 | PF00397 | 0.472 |
MOD_CK1_1 | 118 | 124 | PF00069 | 0.402 |
MOD_CK1_1 | 22 | 28 | PF00069 | 0.452 |
MOD_CK1_1 | 230 | 236 | PF00069 | 0.466 |
MOD_CK1_1 | 68 | 74 | PF00069 | 0.484 |
MOD_CK2_1 | 73 | 79 | PF00069 | 0.515 |
MOD_GlcNHglycan | 1 | 4 | PF01048 | 0.571 |
MOD_GlcNHglycan | 153 | 156 | PF01048 | 0.403 |
MOD_GlcNHglycan | 257 | 260 | PF01048 | 0.489 |
MOD_GlcNHglycan | 70 | 73 | PF01048 | 0.430 |
MOD_GSK3_1 | 115 | 122 | PF00069 | 0.447 |
MOD_GSK3_1 | 230 | 237 | PF00069 | 0.419 |
MOD_GSK3_1 | 246 | 253 | PF00069 | 0.286 |
MOD_GSK3_1 | 61 | 68 | PF00069 | 0.353 |
MOD_N-GLC_1 | 115 | 120 | PF02516 | 0.470 |
MOD_N-GLC_1 | 227 | 232 | PF02516 | 0.474 |
MOD_NEK2_1 | 115 | 120 | PF00069 | 0.422 |
MOD_NEK2_1 | 269 | 274 | PF00069 | 0.492 |
MOD_NEK2_2 | 102 | 107 | PF00069 | 0.486 |
MOD_NEK2_2 | 62 | 67 | PF00069 | 0.486 |
MOD_PKA_2 | 135 | 141 | PF00069 | 0.375 |
MOD_PKA_2 | 68 | 74 | PF00069 | 0.530 |
MOD_Plk_1 | 157 | 163 | PF00069 | 0.387 |
MOD_Plk_4 | 119 | 125 | PF00069 | 0.392 |
MOD_Plk_4 | 193 | 199 | PF00069 | 0.503 |
MOD_Plk_4 | 80 | 86 | PF00069 | 0.414 |
MOD_ProDKin_1 | 214 | 220 | PF00069 | 0.388 |
MOD_ProDKin_1 | 44 | 50 | PF00069 | 0.524 |
MOD_SUMO_rev_2 | 146 | 154 | PF00179 | 0.509 |
TRG_DiLeu_BaEn_2 | 204 | 210 | PF01217 | 0.426 |
TRG_ENDOCYTIC_2 | 7 | 10 | PF00928 | 0.435 |
TRG_Pf-PMV_PEXEL_1 | 240 | 244 | PF00026 | 0.371 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N0P495 | Leptomonas seymouri | 60% | 100% |
A0A0S4JKK5 | Bodo saltans | 25% | 98% |
A0A1X0P327 | Trypanosomatidae | 35% | 96% |
A0A3Q8IPM4 | Leishmania donovani | 77% | 100% |
A0A422NMF9 | Trypanosoma rangeli | 35% | 100% |
A4IDT5 | Leishmania infantum | 77% | 100% |
D0A8T8 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 34% | 100% |
E9ATU7 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 74% | 100% |
Q4Q0P9 | Leishmania major | 74% | 100% |
V5BWK1 | Trypanosoma cruzi | 35% | 100% |